Cannabinoid receptor localization in brain

Proceedings of the National Academy of Sciences of the United States of America

Volumn 87, Issue 5, 1990, Pages 1932-1936

  Herkenham, Miles ^a   Lynn, Allison B ^a   Little, Mark D ^a   Johnson, M Ross ^b   Melvin, Lawrence S ^c   De Costa, Brian R ^d   Rice, Kenner C ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b GLAXOSMITHKLINE   (United States)

^c PFIZER INC   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Autoradiography; Basal ganglia; Cerebellum; Hippocampus; Tetrahydrocannabinol

Indexed keywords

MAMMALIA; ANIMALIA;

BRAIN RECEPTOR; CANNABINOID; DRUG RECEPTOR; RADIOISOTOPE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; HIPPOCAMPUS; HUMAN; HUMAN CELL; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMAL; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; CANNABINOIDS; COMPARATIVE STUDY; CYCLOHEXANOLS; HUMAN; KINETICS; MICE; ORGAN SPECIFICITY; RECEPTORS, DRUG; SPECIES SPECIFICITY; TRITIUM;

EID: 0025236913     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.87.5.1932     Document Type: Article

References (47)

1. Harris, L. S., Dewey, W. L. & Razdan, R. K. (1977) in Handbook of Experimental Pharmacology, ed. Martin, W. R. (Springer, New York), pp. 371-429.
2. Mechoulam, R. (1986) in Cannabinoids as Therapeutic Agents, ed. Mechoulam, R. (CRC, Boca Raton, FL), pp. 1-19.
3. Razdan, R. K. (1986) Pharmacol. Rev. 38, 75-149.
4. Dewey, W. L. (1986) Pharmacol. Rev. 38, 151-178.
5. Hollister, L. E. (1986) Pharmacol. Rev. 38, 1-20.
6. Wilson, R. S. & May, E. L. (1975) J. Med. Chem. 18, 700-703.
7. Wilson, R. S., May, E. L., Martin, B. R. & Dewey, W. L. (1976) J. Med. Chem. 19, 1165-1167.
8. Wilson, R. S., May, E. L. & Dewey, W. L. (1979) J. Med. Chem. 22, 886-888.
9. Johnson, M. R. & Melvin, L. S. (1986) in Cannabinoids as Therapeutic Agents, ed. Mechoulam, R. (CRC, Boca Raton, FL), pp. 121-145.
10. Devane, W. A., Dysarz, F. A. I., Johnson, M. R., Melvin, L. S. & Hewlett, A. C. (1988) Mol. Pharmacol. 34, 605-613.
11. Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. (1988) Mol. Pharmacol. 33, 297-302.
12. Little, P. J., Compton, D. R., Johnson, M. R. & Martin, B. R. (1988) J. Pharmacol. Exp. Ther. 247, 1046-1051.
13. Herkenham, M. (1988) in Molecular Neuroanatomy, eds. van Leeuwen, F., Buijs, R. M., Pool, C. W. & Pach, O. (Elsevier, Amsterdam), pp. 111-120.
14. Rothman, R. B., Schumacher, U. K. & Pert, C. B. (1983) Neuropeptides 3, 493-499.
15. Rothman, R. B. (1986) Alcohol Drug Res. 6, 309-325.
16. McGonigle, P., Neve, K. A. & Molinoff, P. B. (1986) Mol. Pharmacol. 30, 329-337.
17. Rothman, R. B., Long, J. B., Bykov, V., Jacobson, A. E., Rice, K. C. & Holaday, J. W. (1988) J. Pharmacol. Exp. Ther. 247, 405-416.
18. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) J. Biol. Chem. 193, 265-275.
19. Burstein, S. H., Hull, K., Hunter, S. A. & Latman, V. (1988) FASEB J. 2, 3022-3026.
20. Nye, J. S., Seltzman, H. H., Pitt, C. G. & Snyder, S. H. (1985) J. Pharmacol. Exp. Ther. 234, 784-791.
21. Zezula, J., Cortés, R., Probst, A. & Palacios, J. M. (1988) Neuroscience 25, 771-795.
22. Boyson, S. J., McGonigle, P. & Molinoff, P. B. (1986) J. Neurosci. 6, 3177-3188.
23. Richfield, E. K., Young, A. B. & Penney, J. B. (1986) Brain Res. 383, 121-128.
24. Greenamyre, J. T., Young, A. B. & Penney, J. B. (1984) J. Neurosci. 4, 2133-2144.
25. Garrett, E. R. & Hunt, C. A. (1974) J. Pharm. Sci. 63, 1056-1064.
26. Harris, L. S., Carchman, R. A. & Martin, B. R. (1978) Life Sci. 22, 1131-1138.
27. Roth, S. H. & Williams, P. J. (1979) J. Pharm. Pharmacol. 31, 224-230.
28. Worley, P. F., Baraban, J. M., De Souza, E. B. & Snyder, S. H. (1986) Proc. Natl. Acad. Sci. USA 83, 4053-4057.
29. Worley, P. F., Baraban, J. M. & Snyder, S. H. (1986) J. Neurosci. 6, 199-207.
30. Dohlman, H. G., Caron, M. G. & Lefkowitz, R. J. (1987) Biockemistry 26, 2257-2264.
31. Miller, L. L. (1984) in The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects, eds. Agurell, S., Dewey, W. L. & Willette, R. E. (Academic, New York), pp. 21-46.
32. Miller, L. L. & Braconnier, R. J. (1983) Psychol. Bull. 93, 441-456.
33. Aigner, T. G. (1988) Psychopharmacology 95, 507-511.
34. Douglas, R. J. (1967) Psychol. Bull. 67, 416-442.
35. Eichenbaum, H. & Cohen, N. J. (1988) Trends Neurosci. 11, 244-248.
36. Hooker, W. D. & Jones, R. T. (1987) Psychopharmacology 91, 20-24.
37. Schulze, G. E., McMillan, D. E., Bailey, J. R., Scallet, A., Ali, S. F., Slikker, W. J. & Paule, M. G. (1988) J. Pharmacol. Exp. Ther. 245, 178-186.
38. Campbell, K. A., Foster, T. C., Hampson, R. E. & Deadwyler, S. A. (1986) J. Pharmacol. Exp. Ther. 239, 941-945.
39. Kornetsky, C. (1985) NIDA Res. Monogr. 62, 30-50.
40. Di Chiara, G. & Imperato, A. (1988) Proc. Natl. Acad. Sci. USA 85, 5274-5278.
41. Ng Cheong Ton, J. M., Gerhardt, G. A., Friedemann, M., Etgen, A. M., Rose, G. M., Sharpless, N. S. & Gardner, E. L. (1988) Brain Res. 451, 59-68.
42. Stark, P. & Dews, P. B. (1980) J. Pharmacol. Exp. Ther. 214, 124-130.
43. Gardner, E. L., Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D. & Morrison, D. (1988) Psychopharmacology 96, 142-144.
44. Herkenham, M., Lynn, A. B., de Costa, B. & Richfield, E. K. (1989) Soc. Neurosci. Abstr. 15, 905.
45. Marsden, C. D. (1981) in Disorders of Movement, Current Status of Modern Therapy, ed. Barbeau, A. (Lippincott, Philadelphia), Vol. 8, pp. 81-104.
46. Petro, D. J. & Ellenberger, C. E. (1981) J. Clin. Pharmacol. 21, 413s-416s.
47. Clifford, D. B. (1983) Ann. Neurol. 13, 669-671.